Recent

% | $
Quotes you view appear here for quick access.

Lynas Corporation Limited Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • grossorchids grossorchids Jan 3, 2011 1:05 PM Flag

    Australian pond just too small for Lynas

    I think that you are missing the point of my post!

    I think that LYC is currently the BEST play in th REE market and has no equal.

    The post that you referenced is why I believe so!

    As far as the potential price of LYC stock goes this will not be a $50 stock like MCP because of the difference in outstanding shares.

    I really don't understand why companies like MCP and REE are doing as well as they are! MCP is still over a year away from production and with Moonbeam being inaugrated in the next few days I would'nt bet on it! The mine was shut down due to environmental reasons and those conditions still remain.

    REE has nothing except a promising property and at best 4 to 5 years away from production.

    LYC is currently in the drivers seat! They will come into their own this year. I am a long and nothing else!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • grosser child, MCP has already received all of their permits, including the EPA, and have now been blessed with the green light to proceed.

      I live about 3 hours from the MCP open pit mine, and in the next 2 weeks plan on taking a tour of the facility's. Good luck to you, and GO LYNAS

      • 1 Reply to lynasstock
      • The Mountain Pass deposit has been mined since the 1950's and from what I have seen is a huge operation.

        I never had the opportunity to visit the site while I did my graduate work at UNR in the early 80's.

        Low level radiation is a common problem with any RE deposit. Depending upon the minearl assembledge can be quite high.

        Radiation has been a problem at Mountain Pass. Ware your lead lined shorts and take lots of pictures!

        Sounds like a great trip!

 
LYSCF
0.0260.000(0.00%)Jul 30 3:43 PMEDT